Solubilization of naphthoquinones by complexation with hydroxypropyl- β-cyclodextrin

International Journal of Pharmaceutics

Volumn 159, Issue 1, 1997, Pages 13-18

  Linares, Marcela ^a   De Bertorello, María M ^a   Longhi, Marcela ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

1,2 Naphthoquinone; Charge effects; Hydroxypropyl cyclodextrin; Inclusion complexation; Isoxazolylnaphthoquinoneimine; Solubility study

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; 2 HYDROXY N (5 METHYL 3 ISOXAZOLYL) 1,4 NAPHTHOQUINONE 4 IMINE; 2 HYDROXYPROPYL BETA CYCLODEXTRIN; HYDROXYL GROUP; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DRUG SOLUBILITY; DRUG STRUCTURE; PH; PRIORITY JOURNAL;

EID: 0031574001     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00269-X     Document Type: Article

References (14)

1. Backensfeld T., Müller B., Kolter K. Interaction of NSA with cyclodextrins and hydroxypropyl-cyclodextrin derivatives. Int. J. Pharm. 46:1988;217-222.
2. Casarosa M., Longhi M., de Bertorello M.M. Degradation kinetics of a 5-methyl-3-isoxazolylnaphthoquinone derivative in solution. Drug Stability. 1:1996;188-192.
3. Elving P., Markowitz J., Rosenthal I. Preparation of buffers systems of constant ionic strength. Anal. Chem. 28:1956;1179-1180.
4. Fernández A., de Bertorello M.M., Manzo R. Síntesis y propiedades espectroscópicas de 1,2-naftoquinona-4-aminoisoxazoles. Anal. Asoc. Quím. Argentina. 70:1982;49-55.
5. Higuchi, T., Connors, K., 1965. Advances in Analytical Chemistry and Instrumentation, vol. 4. Interscience, New York, pp. 117-212.
6. Johnson M., Hoesterey B., Anderson B. Solubilization of a tripeptide HIV protease inhibitor using a combination of ionization and complexation with chemically modified cyclodextrins. J. Pharm. Sci. 83:1994;1142-1146.
7. Loftsson T., Fridriksdottir H., Olafsdottir B., Gudmundsson O. Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharm. Nord. 3:1991;215-217.
8. Longhi M., Linares M., de Bertorello M.M. High performance liquid chromatography of isoxazolyl-naphthoquinones: a comparison between experimental and theoretical lipophilicity. J. Liq. Chromatogr. Rel. Technol. 19:1996;1947-1956.
9. Müller B., Albers E. Complexation of dihydropyridine derivatives with cyclodextrins and 2-hydroxypropyl-β-cyclodextrin in solution. Int. J. Pharm. 79:1992;273-288.
10. Müller B., Brauns V. Solubilization of drugs by modified β-cyclodextrins. Int. J. Pharm. 26:1985;77-88.
11. Okimoto K., Rajewski R., Uekama K., Jona J., Stella V. The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins. Pharm. Res. 13:1996;256-264.
12. Pedersen M., Edelsten M., Nielsen V., Scarpellini A., Skytte S., Slot C. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int. J. Pharm. 90:1993;247-254.
13. Szejtli, J., 1994. Cyclodextrins in Pharmacy. Kluwer, Dordrecht, The Netherlands.
14. Tinwalla A., Hoesterey T., Xiam T., Lim K., Anderson B. Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-β-cyclodextrin. Pharm. Res. 10:1993;1136-1143.